IRIS
BIANCONI, MARISTELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.967
EU - Europa 1.100
AS - Asia 492
SA - Sud America 163
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 4
Totale 3.794
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.959
IT - Italia 255
UA - Ucraina 193
SG - Singapore 163
BR - Brasile 151
SE - Svezia 120
IE - Irlanda 105
TR - Turchia 105
DE - Germania 104
RU - Federazione Russa 104
CN - Cina 96
FI - Finlandia 79
DK - Danimarca 75
HK - Hong Kong 59
KR - Corea 41
CI - Costa d'Avorio 37
GB - Regno Unito 27
MA - Marocco 24
FR - Francia 14
IN - India 11
BE - Belgio 8
BD - Bangladesh 6
NL - Olanda 6
DZ - Algeria 5
CO - Colombia 4
EU - Europa 4
VE - Venezuela 4
CA - Canada 3
CZ - Repubblica Ceca 3
MX - Messico 3
PL - Polonia 3
SA - Arabia Saudita 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
EC - Ecuador 1
HN - Honduras 1
IQ - Iraq 1
JM - Giamaica 1
JP - Giappone 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 3.794
Salva come PNG Salva come JPEG
Città #
Chandler 236
Fairfield 217
Jacksonville 206
Wilmington 136
Ashburn 111
Dublin 105
Centro 96
Seattle 95
Boardman 94
Singapore 84
Woodbridge 83
Houston 73
Ann Arbor 69
New York 63
Cambridge 59
Hong Kong 59
Des Moines 51
Lawrence 43
Princeton 43
San Mateo 43
Turin 43
Abidjan 36
Moscow 27
The Dalles 25
Beijing 24
Helsinki 21
Turku 20
San Diego 17
Munich 16
Pune 9
Brussels 8
Izmir 8
Los Angeles 8
London 7
Belo Horizonte 6
Brasília 6
Cagliari 6
Chicago 6
Norwalk 6
San Francisco 6
Shanghai 6
São Paulo 6
Wuxi 6
Guangzhou 5
Kilburn 5
Washington 5
Wuhan 5
Dallas 4
Fayetteville 4
Rio de Janeiro 4
Ancona 3
Atlanta 3
Bogotá 3
Curitiba 3
Duque de Caxias 3
Jiaxing 3
Milan 3
New Bedfont 3
Olomouc 3
Porto Alegre 3
Warsaw 3
Amantea 2
Amsterdam 2
Bom Despacho 2
Campinas 2
Clifton 2
Como 2
Council Bluffs 2
Dalian 2
Dhaka 2
Florence 2
Florianópolis 2
Fortaleza 2
Guanhães 2
Guarulhos 2
Istanbul 2
Jinhua 2
Joinville 2
Marche 2
Modena 2
Montesilvano 2
Ottaviano 2
Piracicaba 2
Ponta Grossa 2
Porto 2
Prescot 2
Recife 2
Ribeirão Preto 2
Riyadh 2
Rome 2
Roseto degli Abruzzi 2
Scafati 2
Siena 2
Sorocaba 2
Suzano 2
Venice 2
Acton 1
Alcobaça 1
Alegrete 1
Alto Santo 1
Totale 2.428
Salva come PNG Salva come JPEG
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 147
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 142
Immunotherapy in genitourinary cancers: Where are we going? 142
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 128
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 117
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 110
Il profilo angiogenico nel carcinoma renale metastatico: implicazioni prognostiche e terapeutiche 109
Neutrophil‑to‑lymphocyte ratio may be associated with the outcome in patients with prostate cancer 107
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment 105
Adjuvant treatment after surgical resection 105
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 104
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 100
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 99
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 98
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 98
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 95
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 95
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 93
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 92
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 92
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 92
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 89
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 89
Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients 88
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 88
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 87
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 85
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 84
Panitumumab for the treatment of metastatic colorectal cancer: A review 82
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer 79
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 77
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 75
Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer. 74
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 74
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 71
Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: It is not about the destination, it is about the journey 67
Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study. 65
The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy 64
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 62
VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinoma 61
Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice 61
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma 50
State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors. 48
Totale 3.890
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.653
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202057 0 0 0 0 0 0 0 0 0 0 0 57
2020/2021769 47 71 82 4 126 74 70 48 54 100 64 29
2021/2022370 35 92 4 5 2 19 21 22 18 53 29 70
2022/2023727 53 98 59 48 47 114 1 38 166 3 83 17
2023/2024364 61 2 29 45 54 93 6 11 1 6 8 48
2024/2025819 112 74 10 12 47 29 120 32 139 62 109 73
Totale 3.890